🇺🇸 FDA
Patent

US 12310988

BCMA chimeric antigen receptors and uses thereof

granted A61KA61K2039/505A61K2239/13

Quick answer

US patent 12310988 (BCMA chimeric antigen receptors and uses thereof) held by The Board of Regents of the University of Texas System expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/505, A61K2239/13, A61K2239/21, A61K2239/22